Technocrat

European Commission Not Pleased with Big Pharma

zogger
Sat Nov 29 18:15:00 -0800 2008
Health+and+Medicine.
manage

The European Commissioner for economic competition has been looking into the actions of the large pharmaceutical companies and has found trends where they are trying to stifle the access of generic and cheaper medicines by such things as "patent clustering" around single medicines and excessive interference with national regulating bodies.

"These preliminary results show that market entry of generic companies and the development of new and more affordable medicines is sometimes blocked or delayed, at significant cost to healthcare systems, consumers and taxpayers," Ms Kroes said. ed.z.: Here is her press conference speech transcript: preliminary report of sector inquiry into pharmaceuticals

 

Do you have questions about the site? Write to bruce at perens.com . List of all articles we've ever published. Source Code Developer's Documentation RSS XML Sitemap XML News Sitemap Valid XHTML 1.0 Strict Valid CSS! [Valid RSS]